Acute Lymphoblastic Leukemia (ALL)
Poseidon

Click on Product Name for more information
Click on Catalog# for Application Manual

Product Name Color Catalog#
ON= Oncology probes 10 test, ready-to-use format

ALL Related Probes
ON TEL/AML t(12;21) Fusion red/green KBI-10401
ON p16 (9p21) / 9q21 red/green KBI-10402
ON ETV6 (TEL) (12p13) Break  red/green  KBI-10403

 

Poseidon

Click on Product Name for more information
Click on Catalog# for Application Manual

Product Name Color Catalog#
ON= Oncology probes 10 test, ready-to-use format

ALL Related Probes
ON TEL/AML t(12;21) Fusion red/green KBI-10401
ON p16 (9p21) / 9q21 red/green KBI-10402
ON ETV6 (TEL) (12p13) Break  red/green  KBI-10403

 

   
Acute Lymphoblastic Leukemia (ALL) Minimize

Acute lymphocytic leukemia, also called acute lymphoblastic leukemia, is a type of cancer that starts from white blood cells in the bone marrow. A number of recurring cytogenetic abnormalities are associated with distinct immunologic phenotypes of ALL and characteristic outcomes. The ETV6/AML1 fusion arising from the translocation 
t(12;21)(p13;q22) has been associated with a good outcome; the BCR/ABL fusion of 
t(9;22)(q34;q11), rearrangements of the MLL gene (11q23), and abnormalities of the short arm of chromosomes 9 involving the tumor suppressor genes p16 (INK4A) have a poor prognosis.

Acute lymphocytic leukemia, also called acute lymphoblastic leukemia, is a type of cancer that starts from white blood cells in the bone marrow. A number of recurring cytogenetic abnormalities are associated with distinct immunologic phenotypes of ALL and characteristic outcomes. The ETV6/AML1 fusion arising from the translocation 
t(12;21)(p13;q22) has been associated with a good outcome; the BCR/ABL fusion of 
t(9;22)(q34;q11), rearrangements of the MLL gene (11q23), and abnormalities of the short arm of chromosomes 9 involving the tumor suppressor genes p16 (INK4A) have a poor prognosis.